Dolphin Medical Services Limited (BOM:526504)
India · Delayed Price · Currency is INR 7.20
-0.29 (-3.87%)
At close: Aug 17, 2026
Dolphin Medical Services Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 7.88 | 7.5 | 7.79 | 6.79 | 6.11 | 5.2 |
Other Revenue | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 |
| 8.24 | 7.87 | 8.16 | 7.15 | 6.48 | 5.57 | |
Revenue Growth | -2.37% | -3.60% | 14.10% | 10.39% | 16.31% | -90.75% |
Cost of Revenue | 2.79 | 2.52 | 2.71 | 2.78 | 2.42 | 2.21 |
Gross Profit | 5.46 | 5.35 | 5.46 | 4.38 | 4.06 | 3.36 |
Selling, General & Admin | - | - | 1.21 | 1.19 | 1.11 | 1.11 |
Other Operating Expenses | 3.87 | 3.74 | 3.82 | 3.59 | 3.4 | 3.29 |
Operating Expenses | 4.89 | 4.64 | 5.66 | 5.24 | 5.14 | 5.03 |
Operating Income | 0.57 | 0.71 | -0.21 | -0.87 | -1.08 | -1.67 |
Interest Expense | -0.1 | -0.1 | -0.1 | -0.1 | -0.09 | -0.09 |
EBT Excluding Unusual Items | 0.48 | 0.61 | -0.3 | -0.96 | -1.18 | -1.76 |
Pretax Income | 0.48 | 0.61 | -0.3 | -0.96 | -1.18 | -1.76 |
Income Tax Expense | 0.19 | 0.19 | 0.03 | 0.08 | 0.07 | 0.11 |
Net Income | 0.28 | 0.42 | -0.34 | -1.04 | -1.25 | -1.87 |
Net Income to Common | 0.28 | 0.42 | -0.34 | -1.04 | -1.25 | -1.87 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 17 | 21 | 17 | 15 | 16 | 16 |
Shares Outstanding (Diluted) | 17 | 21 | 17 | 15 | 16 | 16 |
Shares Change | -4.36% | 23.96% | 13.71% | -4.56% | -0.32% | 5.08% |
EPS (Basic) | 0.02 | 0.02 | -0.02 | -0.07 | -0.08 | -0.12 |
EPS (Diluted) | 0.02 | 0.02 | -0.02 | -0.07 | -0.08 | -0.12 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -3.18 | -0.6 | -0.45 | -0.69 | -0.99 |
Free Cash Flow Per Share | - | -0.15 | -0.04 | -0.03 | -0.04 | -0.06 |
Gross Margin | 66.21% | 68.00% | 66.83% | 61.16% | 62.65% | 60.34% |
Operating Margin | 6.95% | 9.00% | -2.55% | -12.14% | -16.72% | -29.93% |
Profit Margin | 3.45% | 5.33% | -4.14% | -14.54% | -19.23% | -33.65% |
Free Cash Flow Margin | - | -40.41% | -7.32% | -6.29% | -10.66% | -17.71% |
EBITDA | 1.54 | 1.61 | 0.42 | -0.4 | -0.46 | -1.04 |
EBITDA Margin | 18.73% | 20.46% | 5.13% | -5.64% | -7.04% | -18.68% |
D&A For EBITDA | 0.97 | 0.9 | 0.63 | 0.47 | 0.63 | 0.63 |
EBIT | 0.57 | 0.71 | -0.21 | -0.87 | -1.08 | -1.67 |
EBIT Margin | 6.95% | 9.00% | -2.55% | -12.14% | -16.72% | -29.93% |
Effective Tax Rate | 40.46% | 31.54% | - | - | - | - |
Revenue as Reported | 8.24 | 7.87 | 8.16 | 7.15 | 6.48 | 5.57 |
Advertising Expenses | - | - | 0.09 | 0.08 | 0.08 | 0.08 |